Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

PFIZER LTD.

NSE : PFIZERBSE : 500680ISIN CODE : INE182A01018Industry : Pharmaceuticals & DrugsHouse : Pfizer - MNC

BSE4395.9560.05 (+1.38 %)

PREV CLOSE ( ) 4335.90

OPEN PRICE ( ) 4211.05

BID PRICE (QTY) 4398.10 (3)

OFFER PRICE (QTY) 4405.00 (2)

VOLUME 381

TODAY'S LOW / HIGH ( )4211.05 4405.00

52 WK LOW / HIGH ( )3729.85 4940

NSE4398.7063.2 (+1.46 %)

PREV CLOSE( ) 4335.50

OPEN PRICE ( ) 4357.00

BID PRICE (QTY) 4393.75 (1)

OFFER PRICE (QTY) 4398.70 (3)

VOLUME 3455

TODAY'S LOW / HIGH( ) 4338.05 4399.85

52 WK LOW / HIGH ( )3720 5000

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 21-11 1950

Management Info

Pradip Shah - Chairman Meenakshi Nevatia - Managing Director

Registered Office

Address The Capital, 1802/1901,Plot No. C-70, G Block,Bandra Kurla Complex, Bandra (East),
Mumbai,
Maharashtra-400051

Phone 022 6693 2000

Email contactus.india@pfizer.com

Website www.pfizerltd.co.in

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE, MCX

NEWS

12Apr Intimation Regarding Appointment Of C
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we hereby in..

22Jan Pfizer informs about appointment of ex
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..

18Aug Pfizer informs about change in managem
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..

20Jul Pfizer informs about loss of share cer
Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (..

20Jun Pfizer informs about loss of share cer
Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (..

Financials

Rs. in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	1299.8	6239.3
Gross Profit	1759.4	8240.1
Operating Profit	1884	9099.1
Net Sales	5399.7	24247.6

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE) 8854.30 (3.31%)	M.Cap ( in Cr)20289.98
Astrazeneca Pharma I (BSE) 5798.30 (2.82%)	M.Cap ( in Cr)14220.00
Mankind Pharma (BSE) 2127.15 (1.68%)	M.Cap ( in Cr)85415.41
AMI Organics (BSE) 1257.40 (2.21%)	M.Cap ( in Cr)4563.42
Zydus Lifesciences (BSE) 1031.20 (2.23%)	M.Cap ( in Cr)103118.86

Shareholding Pattern

	PROMOTERS	63.92%
	NON-INSTITUTION	17.42%
	MUTUAL FUNDS/UTI	7.72%
	FI/BANKS/INSURANCE	7.45%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Samco ELSS Tax Save...	2.41
HDFC Pharma and Hea...	2.22
Aditya Birla SL MNC...	2.04
HDFC MNC Fund-Reg(G)	1.97
Nippon India Pharma...	1.87
UTI Healthcare Fund...	1.68
UTI Dividend Yield ...	1.40

Risk Disclosures on Derivatives

Smart Quotes

PFIZER LTD.